Modulatory effect of interleukin-1β on rat isolated basilar artery contraction

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 238-245

  Seto, Sai Wang ^a   Kwan, Yiu Wa ^a   Ngai, Sai Ming ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adrenergic agonist; Interleukin; MAP kinase; Vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA 1 ADRENERGIC RECEPTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PERILLIC ACID; PHENYLEPHRINE; PRAZOSIN; PROTEIN P21; PROTEIN P42; PROTOPORPHYRIN ZINC; SYNAPTOPHYSIN; TETRODOTOXIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TENSION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BASILAR ARTERY; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYCLOHEXENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; IMIDAZOLES; INTERLEUKIN-1; MALE; MONOTERPENES; PHENYLEPHRINE; PRAZOSIN; PROTOPORPHYRINS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; TETRODOTOXIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 32044435589     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.038     Document Type: Article

References (58)

1. A.L.S. Au, Y.W. Kwan, C.C. Kwok, R.Z. Zhang, and G.W. He Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery Eur. J. Pharmacol. 468 2003 199 207
2. D. Beasley, R.A. Cohen, and N.G. Levinsky Interleukin 1 inhibits contraction of vascular smooth muscle J. Clin. Invest. 83 1989 331 335
3. G.J. Blake, and P.M. Ridker Inflammatory bio-markers and cardiovascular risk prediction J. Intern. Med. 242 2002 283 294
4. 2+ antagonist RO 40-5967 on endothelium-dependent responses of isolated arteries J. Cardiovasc. Pharmacol. 23 1994 869 876
5. G. Bunc, S. Kovacic, and S. Strnad Evaluation of functional response of cerebral arteries by a new morphometric technique Auto. Neurosci. 93 2001 41 47
6. W.Y. Choy, Y.F. Wong, Y.W. Kwan, A.L.S. Au, W.H. Lau, K. Raymond, and J.Z. Zuo Role of mitogen-activated protein kinase pathway in acetylcholine-mediated in vitro relaxation of rat pulmonary artery Eur. J. Pharmacol. 434 2002 55 64
7. C.A. Dinarello Interleukin-1 Cytokine Growth Factor Rev. 8 1997 253 265
8. J. Eder Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? TiPS 18 1997 319 322
9. D. El-Assouad, and S.K. Tayebati Cholinergic innervation of pial arteries in senescent rats: an immunohistochemical study Mech. Ageing Dev. 123 2002 529 536
10. S.R. Feldman, J.S. Meyer, and L.F. Quenzer Principles of Neuropsychopharmacology 1997 Sinauer Associates Inc., Publishers
11. L. Friberg, J. Olesen, H.K. Iversen, and B. Sperling Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan Lancet 338 1991 13 17
12. K. Fujii, D.D. Heistad, and F.M. Faraci Vasomotion of basilar arteries in vivo Am. J. Physiol. 258 1990 H1829 H1834
13. i coupling and Src-dependent phosphorylation of the epidermal growth factor receptor J. Pharmacol. Exp. Ther. 296 2001 426 433
14. Y. Handa, Y. Nojyo, N. Tamamaki, A. Tsuchida, and T. Kubota Development of the sympathetic innervation to the cerebral arterial system in neonatal rats as revealed by anterograde labelling with wheat germ agglutinin-horseradish peroxidase Exp. Brain Res. 94 1993 216 224
15. S.J. Hopkins, and N.J. Rothwell Cytokines in the nervous system I: expression and recognition TiNS 18 1995 83 88
16. D.S. Houston, and P.M. Vanhoutte Serotonin and the vascular system. Role in health and disease, and implications for therapy Drugs 31 1986 149 163
17. T. Kitazono, S. Ibayashi, T. Nagao, T. Kagiyama, J. Kitayama, and M. Fujishima Role of tyrosine kinase in serotonin-induced constriction of the basilar artery in vivo Stroke 29 1998 494 497
18. Y.W. Kwan, R.M. Wadsworth, and K.A. Kane Effects of hypoxia on the pharmacological responsiveness of isolated coronary artery rings from the sheep Br. J. Pharmacol. 96 1989 849 856
19. + channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats Eur. J. Pharmacol. 365 1999 241 251
20. M.C. LaPointe, and E. Isenovic Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signalling pathways in cardiac myocytes Hypertension 33 1999 276 282
21. J.J. Legos, R.G. Whitmore, J.A. Erhardt, A.A. Parsons, R.F. Tuma, and F.C. Barone Quantitative changes in interleukin proteins following focal stroke in the rat Neurosci. Lett. 282 2000 189 192
22. X. Lin, S.K. Ramamurthy, and G.C. Le Breton Thromboxane a receptor-mediated cell proliferation, survival and gene expression in oligodendrocytes J. Neurochem. 93 2005 257 268
23. D. Luo, and S.R. Vincent Metalloporphyrins inhibits nitric oxide dependent cGMP formation in vivo Eur. J. Pharmacol. 267 1994 263 267
24. M.R. MacLean, G. Sweeney, M. Baird, K.M. McCulloch, M. Houslay, and I. Morecroft 5-Hydroxytryptamine receptors mediated vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats Br. J. Pharmacol. 119 1996 917 930
25. K. Matrougui, J. Maclouf, B.I. Levy, and D. Henrion Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats Hypertension 30 1997 942 947
26. L. Morgan, and S.E. Humphrines The genetic of stroke Curr. Opin. Lipidol. 16 2005 193 199
27. M.A. Murray, F.M. Faraci, and D.D. Heistad Role of protein kinase C in constrictor responses of the rat basilar artery in vivo J. Physiol. 445 1992 169 179
28. Y.M. Murtha, B.M. Allen, and A.O. James The role of protein kinase C in thromboxane A2-induced pulmonary artery vasoconstriction J. Biomed. Sci. 6 1999 293 295
29. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
30. G. Noll, and T.F. Luscher The endothelium in acute coronary syndromes Eur. Heart J. 19 1998 C30 C38
31. K. Osuka, Y. Suzuki, Y. Watanabe, A. Dogan, M. Takayasu, M. Shibuya, and J. Yoshida Vasodilator effects on canine basilar artery induced by intracisternal interleukin-1 beta J. Cereb. Blood Flow Metab. 17 1997 1337 1345
32. P. Pickker, M.G. Netea, J.W.M. Van der Meer, and P. Smits TNF and IL-1 exert no direct vasoactivity in human isolated resistance arteries Cytokine 20 2002 244 246
33. R. Robert, B. Chapelain, and G. Neliat Different effects of IL-1 on reactivity of arterial vessels isolated from various vascular beds in the rabbit Circ. Shock 40 1993 139 143
34. N.J. Rothwell Cytokines - killers in the brain? J. Physiol. 514 1999 3 17
35. H.J. Rothwell, and G.N. Luheshi Pharmacology of interleukin-1 actions in the brain Adv. Pharmacol. 25 1994 1 20
36. N.J. Rothwell, S.A. Loddick, and P. Stroemer Interleukins and cerebral ischaemia Int. Rev. Neurobiol. 40 1997 281 298
37. J. Saklatvala, L. Rawlinson, R.J. Waller, S. Sarsfield, J.C. Lee, M.J. Barnes, and R.W. Farndale Role of p38 mitogen-activated protein kinase caused by collagen or a thromboxane analogue J. Biol. Chem. 271 1996 6586 6589
38. S. Salomone, N. Morel, and T. Godfraind Role of nitric oxide in the contractile response to 5-hydroxytryptamine of the basilar artery from Wistar Kyoto and stroke-prone rats Br. J. Pharmacol. 121 1997 1051 1058
39. S. Satoh, Y. Suzuki, T. Harada, I. Ikegaki, T. Asano, M. Shibuya, K. Sugita, and A. Saito The role of platelets in the development of cerebral vasospasm Brain Res. Bull. 27 1991 663 668
40. E.D. Schmidt, A.N.M. Schoffelmeer, T.J. De Vries, G. Wardeh, G. Dogterom, J.G. Bol, R. Binnekade, and F.J. Tilders A single administration of interleukin-1 or amphetamine induces long-lasting increases in evoked noradrenaline release in the hypothalamus and sensitization of ACTH and corticosterone responses in rats Eur. J. Neurosci. 13 2001 1923 1930
41. B. Sperlagh, M. Baranyi, G. Hasko, and S.E. Vizi Potent effect of interleukin-1β (to evoke ATP and adenosine release from rat hippocampal slices J. Neuroimmunol. 151 2004 33 39
42. J. Takada, S. Ibayashi, T. Nagao, H. Ooboshi, T. Kitazono, and M. Fujishima Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats Stroke 32 2001 1216 1219
43. + channel opening to the interleukin-1 beta - induced inhibition of vascular smooth muscle contraction J. Vet. Med. Sci. 61 1998 357 360
44. K. Tasaki, M. Hori, H. Ozaki, H. Karaki, and I. Wakabayashi Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstriction J. Smooth Muscle Res. 39 2003 107 117
45. O. Touzani, H. Boutin, J. Chuquent, and N. Rothwell Potential mechanisms of interleukin-1 involvement in cerebral ischaemia J. Neuroimmunol. 100 1999 203 215
46. G.J. Trachte Thromboxane agonist (U46619) potentiates norepinephrine efflux from adrenergic nerves J. Pharmacol. Exp. Ther. 237 1986 473 477
47. M.H. Tsai, and M.J. Jiang Extracellular signal-regulated kinase 1/2 in contraction of vascular smooth muscle Life Sci. 76 2005 877 888
48. S.H. Tsai, J.M. Tew, and M.T. Shipley Cerebral arterial innervation: II. Development of calcitonin-gene-related peptide and norepinephrine in the rat J. Comp. Neurol. 279 1989 1 12
49. 2+ channels Stroke 35 2004 1709 1714
50. B receptor-mediated contraction Eur. J. Pharmacol. 376 1999 223 232
51. E. Vicaut, C. Rasetti, and N. Baudry Effects of tumor necrosis factor and interleukin-1 on the constriction induced by angiotension II in rat aorta J. Appl. Physiol. 80 1996 1891 1897
52. E. Vila, and M. Salaices Cytokines and vascular reactivity in resistance arteries J. Physiol. 288 2004 H1016 H1021
53. A. Virids, and E.L. Schiffrin Vascular inflammation: a role in vascular disease in hypertension? Curr. Opin. Nephrol. Hypertens. 12 2003 181 187
54. J.H. Von der Thusen, J. Kuiper, T.J.C. Van Berkel, and E.A.L. Biessen Interleukins in atherosclerosis: molecular pathways and therapeutic potential Pharmacol. Rev. 55 2003 133 166
55. S.W. Watts, C.H. Yeum, G. Campbell, and R.C. Webb Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase J. Vasc. Res. 33 1996 288 298
56. B receptor-mediated contraction in human temporal artery Eur. J. Pharmacol. 406 2000 117 122
57. K. Yabuuchi, M. Minami, S. Katsumata, A. Yamasaki, and M.A. Satoh An in situ hybridization study of interleukin-1 beta induced by transient forebrain ischaemia in the rat brain Mol. Brain Res. 26 1994 135 142
58. Y. Yamasaki, N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama, and K. Kogure Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats Stroke 26 1995 676 681